Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2006 054 561.4 |
96 | EP file number | EAKZ | 12 17 5198.6 |
97 | EP publication number | EPN | 2540820 |
54 | Designation/title | TI | MITTEL UND VERFAHREN ZUR BEEINFLUSSUNG DER STABILITÄT VON ANTIKÖRPER-PRODUZIERENDEN ZELLEN |
51 | IPC main class | ICM (ICMV) | C12N 5/0781 (2010.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C12N 5/10 (2006.01), C07K 16/00 (2006.01), C12P 21/08 (2006.01) |
22 | DE application date | DAT | Dec 8, 2006 |
96 | EP application date | EAT | Dec 8, 2006 |
43 | Date of first publication | OT | Jan 2, 2013 |
| Date of publication of grant | PET | Jan 10, 2018 |
71/73 | Applicant/owner | INH | Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, NL; Kling Biotherapeutics B.V., Amsterdam, NL |
72 | Inventor | IN | Spits, Hergen, San Mateo, CA 94402, US; Scheeren, Ferenc Alexander, 5171 WN Kaatsheuvel, NL; Beaumont, Tim, 1191 GM Ouderkerk a/d Amstel, NL; Diehl, Sean Andrew, 2023 SG Haarlem, NL |
| Address for service | | Vereenigde Octrooibureaux N.V., 2508 Den Haag, NL |
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 06076211 Jun 12, 2006
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| WO PCT/NL2005/000848 Dec 9, 2005
|
| Due date | FT FG | Dec 31, 2025 Annual fee for the 20th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002540820 Searchable text:
EP000002540820 Original document:
EP000002540820B1 Searchable text:
EP000002540820B1 |
43 | Date of first publication | EVT | Jan 2, 2013 |
| Date of the first transfer into DPMAregister | EREGT | Feb 15, 2013 |
| Date of the (most recent) update in DPMAregister | REGT | Dec 18, 2024 (Show all update days)(Hide all update days)- Dec 18, 2024
- Dec 21, 2023; Dec 17, 2022; Mar 31, 2022; Feb 19, 2022; Jan 9, 2022; Dec 21, 2021; Dec 18, 2021; Mar 30, 2021; Dec 18, 2019; Aug 13, 2019; Mar 7, 2019; Dec 19, 2018; Nov 22, 2018; Feb 28, 2018; Feb 6, 2018; Jan 10, 2018; Jan 4, 2018; Aug 3, 2017; Jul 13, 2017
- Historical data not available for this/these date(s)
- Feb 15, 2013
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Feb 18, 2022 |
| Issue number | HN | 13 |
| Year | PJ | 2022 |
| Publication date | VT | Mar 31, 2022 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, NL; Kling Biotherapeutics B.V., Amsterdam, NL |
71/73 | Previous applicant/owner | INHF | Academisch Medisch Centrum bij de Universiteit van Amsterdam, Amsterdam, NL, AIMM Therapeutics B.V., AMSTERDAM, NL |
| Date of update of the procedure | REGT | Mar 31, 2022 |